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Abstract
Life-course experiences have been postulated to program hypothalamus–pituitary–adrenal (HPA) axis activity, suggesting that HPA axis
activity is, at least partially, stable over time. Yet, there is paucity of data on the long-term stability of cortisol production and metabolism.
We performed a prospective follow-up study in twins recruited from a nationwide register to estimate the stability of cortisol production and
metabolism over time, and the contribution of genetic and environmental factors to this stability. In total, 218 healthy mono- and dizygotic
twins were included. At the ages of 9, 12 and 17 years, morning urine samples were collected for assessment (by gas chromatography-tandem
mass spectrometry) of cortisol metabolites, enabling the calculation of cortisol metabolite excretion rate and cortisol metabolism activity. Our
results showed a low stability for both cortisol metabolite excretion rate (with correlations<.20) and cortisol metabolism activity indices (with
correlations of .25 to .46 between 9 and 12 years,−.02 to .15 between 12 and 17 years and .09 to .28 between 9 and 17 years). Because of the low
stability over time, genetic and environmental contributions to this stability were difficult to assess, although it seemed to be mostly deter-
mined by genetic factors. The low stability in both cortisol production andmetabolism between ages 9 and 17 years reflects the dynamic nature
of the HPA axis.
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The hypothalamic–pituitary–adrenal (HPA) axis regulates gluco-
corticoid homeostasis. The hypothalamus secretes corticotrophin
releasing hormone, which stimulates the pituitary to release
adrenocorticotrophin (ACTH; Liyanarachchi et al., 2017). ACTH, in
turn, stimulates the adrenal cortex to secrete cortisol. Cortisol is
metabolized by various enzymes, including A-ring reductases,
11β-hydroxysteroid dehydrogenase type 2 (11β-HSD type 2) and
cytochrome P450 (CYP) 3A4 (Figure 1). Long-lasting alterations
in HPA axis activity have been associated with disease susceptibility,
including increased risks of cardiovascular, auto-immune and
psychiatric conditions, suggesting that the settings of this axis are
critical for wellbeing (Dekker et al., 2008; Liyanarachchi et al.,
2017; Silverman & Sternberg, 2012; Tzioufas et al., 2008; Zorn et al.,
2017).
Life-course experiences may permanently alter the settings of
the HPA axis, suggesting that HPA axis activity is, at least partially,
stable over time (Barker, 1993; Hanson&Gluckman, 2014;Weaver
et al., 2004).We recently demonstrated in a twin study with 8 years
of follow-up that the contribution of unshared environmental fac-
tors on cortisol production was already high at the age of 9 years
and continued to increase with age, suggesting that cortisol pro-
duction is mainly determined by individual experiences (van
Keulen et al., 2020). However, it is unclear if the responsible envi-
ronmental factors are consistent or change with time. In the same
study, we showed that cortisol metabolism was mainly determined
by genetic factors. Heritability of the activities of A-ring reductases
was found to increase with age, while for the activities of 11β-HSD
isoenzymes and CYP 3A4 heritability peaked at 12 years (van
Keulen et al., 2020).
Despite this evidence, there is limited data on the long-term sta-
bility of cortisol. To the best of our knowledge, only few studies in
children have reported on the long-term stability of cortisol. A
study among 410 adolescents, in whom the cortisol awakening
response (CAR) was assessed annually over a 3-year period,
reported a low stability of .15 at awakening and .24 at 30 and
60min post-awakening (Platje et al., 2013). In a sample of 357
children, diurnal cortisol slopes were assessed at the ages of 9,
11, 13 and 15 years. After accounting for situation-specific sources
in HPA axis activity and short-term cortisol stability, 13.2% of the
variance in cortisol levels was stable across the 6 years of follow-up,
while the remainder was explained by day-to-day or within-day
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fluctuations (Shirtcliff et al., 2012). Moreover, evidence from three
studies showed that approximately 50% of the variance in salivary
cortisol was dependent on day-to-day fluctuations. Of all param-
eters that were assessed, the total daily cortisol output was most
stable, followed by the diurnal cortisol slope and the CAR (Ross
et al., 2014).
These studies provide evidence regarding the limited long-term
stability in circulating cortisol, but several questions remain unan-
swered. First, these studies only measured cortisol in saliva.
Therefore, the question arises as to which extent the production
and metabolism of cortisol account for this low stability. In addi-
tion, it remains unclear whether this low stability is indeed
explained by environmental factors, such as early-life experiences,
or by genetic factors. Therefore, the purpose of this study was to
test the stability of cortisol production and metabolism over time
between ages 9 and 17 years, in a cohort of twins, as well as the
contributions of genetic and environmental factors to this stability.
Methods
Participants
Nine-year-old twins were recruited from the Netherlands Twin
Register, a nationwide twin register (Boomsma et al., 2006).
Parents were approached for their offspring to take part in the
BrainScale study, which is a prospective follow-up study on the
development of cognition, hormones, and brain structure and
function, as described previously (Teeuw et al., 2018; van Soelen
et al., 2012). The parents of twins born between 1995 and 1996
received a letter 4–8 weeks before the 9th birthday of their children.
Two weeks later, the parents were approached by phone with fur-
ther explanation about the study, and to ask if they consented to
their children taking part. Written informed consent was obtained
from parents at the ages of 9 and 12 years. At the third measure-
ment occasion (around age 17), twins signed for themselves.
The BrainScale study was approved by the Central Committee
on Research Involving Human Subjects of The Netherlands
(CCMO), and studies were performed in accordance with the
Declaration of Helsinki. In total, 214 families were approached,
of which 109 consented to take part (51%). In the follow-up study,
78% and 73% of the participants provided samples at the ages of
12 and 17 years, respectively.
Zygosity was established by genome-wide DNA markers
(Ligthart et al., 2019). DNA samples were tested for genome-wide
single nucleotide polymorphic markers (Scheet et al., 2012). Based
on their zygosity and sex, twins were categorized in the following
groups: monozygotic males (MZMs), dizygotic males (DZMs),
monozygotic females (MZFs), dizygotic females (DZFs) or dizy-
gotic opposite-sex pairs. Information on demographics was
collected at the time of registration by questionnaire (Gielen et al.,
2010).
Study Protocol
At the ages of 9, 12 and 17 years, participants were requested to
collect morning urine immediately after awakening in the provided
tubes and to store them in their refrigerator prior to the study visit.
Samples were subsequently stored at −20 and −80°C and thawed
once just before analysis.
Laboratory Analysis
Analyses were carried out at the Edinburgh Clinical Research
Facility Mass Spectrometry Core Laboratory. Gas chromatography-
tandem mass spectrometry was conducted in order to determine
glucocorticoid metabolites (Homer et al., 2017). Samples were ana-
lyzed in 15 batches. Creatinine concentrations weremeasured by the
Jaffé method (Apple et al., 1986). Enzymatic activities were inferred
through ratios of cortisol metabolites, as depicted in Table 1.
Twin Modeling
Monozygotic (MZ) twins share 100% of their alleles identical by
descent (IBD), while dizygotic (DZ) twins share on average 50%
of their alleles IBD (Boomsma et al., 2002). This difference in
genetic relatedness enables us to estimate the contributions of
genetic and environmental factors to a trait by comparing
within-pair correlations between MZ and DZ twins. A MZ corre-
lation higher than the DZ correlation indicates an influence of
genetic factors, which may be additive (A) or non-additive (genetic
dominance; D). The proportion of phenotypic variance that can be
attributed to genetic factors is termed ‘heritability’. In addition,
resemblance between twins can be explained by common environ-
mental influences (C), defined as the environmental factors that
make family members similar to each other. The presence of
common environmental factors is suggested when the correlation
Fig. 1. Schematic overview of cortisol metabolism. THF, tetrahydrocortisol; THE,
tetrahydrocortisone; aTHF, allotetrahydrocortisol; 6β-OH-cortisol, 6β-hydroxy-
cortisol; HSD, hydroxysteroid dehydrogenase; CYP, cytochrome P.
Table 1. Ratios indicating enzyme activity
Urine metabolites Index
(THFþ allo-THFþ THEþ α-cortolþ
β-cortolþ α-cortoloneþ β-cortolone)/
creatinine
Cortisol metabolite excretion
rate
allo-THF/cortisol 5α-reductase activity
THE/cortisone 5β-reductase activity
Cortisol/cortisone 11β-HSD type 2 activity
6-OH cortisol/cortisol Cytochrome P450 3A4 activity
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in DZ twins is larger than half of the correlation in MZ twins.
Unique environmental factors (E) are not shared between family
members, and so contribute to the phenotypic variance but not
to the phenotypic covariance between twins. Generally, E includes
measurement error.
Statistical Analyses
Outliers, defined as any value ≥3 SD above the phenotypic mean
(on average six per index) and twin pairs with highly discordant
outcomes (on average one per index) were, given their impact
on the MZ and DZ correlations, excluded from statistical analyses.
In order to correct for batch effects, a random effect model was
fitted to the twin data, which included batch as a random effect
(Odintsova et al., 2018).
Structural equation modeling, implemented in the OpenMx
Package in R 3.4.2., was used in all analyses to estimate the
phenotypic correlations (Rph) between observed traits and the
relative contributions of genetic and environmental effects to this
correlation (Boker et al., 2011). For each phenotypic measure, we
fitted a trivariate model to the data in which variables assessed at
the age of 9, 12 and 17 years were analyzed simultaneously. Based
on our previous work (van Keulen et al., 2020), we fitted a model
that allowed for additive genetic, common environmental and
unique environmental effects (i.e., the ACE model). The twin
correlations in 5β-reductase activity [tetrahydrocortisol (THF)/
cortisol] and the balance of 11β-HSD activities [(THFþ
allo-THF)/THE] were hard to interpret at the ages of 12 and
17 (5β-reductase activity: MZ correlations: .00 and .65; DZ cor-
relations 5β-reductase activity: .25 and .06 at the ages of 12 and
17 years, respectively, balance of 11β-HSD activities: MZ correla-
tion: .25; DZ correlation: .04 at the age of 12 years). We attributed
this to sampling fluctuation, in view of the modest sample size,
and discarded these phenotypes. The trivariate model provides
information concerning the contributions of genetic and envi-
ronmental factors to the variance of each phenotype, and to
the phenotypic covariance (or correlation) among the pheno-
types. As mentioned above, the proportion of the phenotypic
variance that can be attributed to genetic factors is an estimate
of standardized genetic variance, which is also known as the her-
itability (h2). Standardized common environmental factors (c2)
and unique environmental (e2) variance similarly represent pro-
portions of phenotypic variance (i.e., h2þ c2þ e2 = 1). Genetic
effects can contribute to the phenotypic covariance between
the phenotype at different ages, if same genes contribute to the
variance at different ages. This also applies to environmental fac-
tors. Just as the standardized variance is expressed in terms of
standardized variance components (h2, c2 and e2), the correlation
of the phenotype at different ages can be expressed in terms of
standardized components. To explain this, we consider the phe-
notype of interest measured at the ages of 9 and 12 (the same
applies to ages 9 and 17, and ages 12 and 17). On the one hand,
we have the variance components h92, c92 and e92 at the age of
9 and h122, c122 and e122 at the age of 12. The decomposition of the
phenotypic correlation rPh9,12 depends both on the standardized
variance components and on the correlation between the A factors
at the ages of 9 and 12 (rA9,12) and the correlation between the
C and the E factors at the ages of 9 and 12 (rC9,12 and rE9,12,
respectively; see Figure 2). The phenotypic correlation is modeled
as rPh9,12= h9 * rA9,12 * h12þ c9 * rC9,12 * c12þ e9 * rE9,12 * e12 (see
Figure 2).
Note that the additive genetic correlation rA9,12 can only be esti-
mated if both h92 and h122 are greater than zero. Clearly if, say, h122
is zero, then there are no genetic effects at the age of 12, and con-
sequently no genetic overlap between ages 9 and 12. So if h122 (or
h92) is zero, the genetic correlation rA9,12 is necessarily fixed to zero
in the analysis. In practice, if either h9 or h12 is relatively small, it is
difficult to obtain a stable estimate of rA9,12 (the same applies to the
environmental contributions to the phenotypic correlation). In
practice this means that the correlation rA9,12 (rC9,12, rE9,12) is esti-
mated only if h9 (c9, e9) and (c12, e12) are appreciably greater than
zero. Therefore, we decided to fix the influence of these factors to
zero if they were 10% or smaller.
Results
A total of 218 twins were enrolled in this study, including 94 MZ
and 124 DZ twins. The MZ pairs included 23 male (MZM) and 24
female (MZF) twin pairs. The DZ twins included 22 male (DZM),
21 female (DZF) and 19 DZ opposite-sex (DOS) twin pairs. There
was an equal sex distribution. Participants were tested at a mean
(SD) age of 9.1 (±0.1), 12.2 (±0.3) and 17.2 (±0.2) years. Mean
(±SD) gestational age was 36.8 weeks (±1.72), and mean (±SD)
birthweight was 2602 g (±475). Mean SD scores (±SD) for body
mass index [weight (kg)/height (m)2] were 0.14 (± 0.93), 0.45
(± 1.00) and 0.27 (±1.08) at the ages of 9, 12 and 17 years, respec-
tively. Mean SD scores for weight (kg) were 0.31 (±0.93), 0.23
(±0.99) and 0.26 (±1.06), and for height (cm) were 0.04 (±0.82),
−0.56 (±0.98) and −0.16 (0.88) at the ages of 9, 12 and 17 years,
respectively (TNO, 2010).
Stability of Cortisol Production and Metabolism Over Time
Table 2 presents the stability over time for cortisol metabolite
excretion rate and cortisol metabolism activities. Correlations were
relatively low (Rph=−.02 to .46). Cortisol metabolite excretion
rates at the ages of 9 and 12 years were correlated with one another
Fig. 2. Path diagram representing the bivariate ACE model.
Note: Phenotypic variance age 9 (Ph9) equals h92þ c92þ e92= 1, phenotypic variance
age 12 (Ph12) equals h122þ c122þ e122= 1 and phenotypic correlation between ages
9 and 12 years (rPh9,12) equals h9 * rA9,12 * h12þ c9 * rC9,12 * c12þ e9 * rE9,12 * e12.
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(Rph= .19). Between ages 9 and 17 years, and 12 and 17 years, no
significant correlations were found for cortisol metabolite
excretion rate. For cortisol metabolism, significant correlations
were found between ages 9 and 12 years for the activities of 5α-
reductase, 5β-reductase, 11β-HSD type 2 and CYP3A4 activities
(Rph= .25, .26, .27 and .46, respectively), and between ages 9
and 17 years for 5α-reductase activity only (Rph = .28).
Contribution of Genetic Versus Environmental Factors
Table 2 also presents genetic and environmental correlations to the
stability of our outcomes. Estimates of these correlations were
often imprecise, as indicated by the wide 90% confidence intervals,
which is likely due to the low phenotypic stability over time.
Trivariate genetic analyses (Table 2, Figure 3) showed that cor-
tisol metabolism correlations were predominantly driven by genetic
factors, especially between ages 9 and 12 years. Additionally, the
influence of environmental factors on the stability of cortisol
metabolism was not statistically significant.
Discussion
We described the stability of cortisol production and metabolism
over time in healthy twins assessed at the ages of 9, 12 and 17 years,
as well as the contribution of genes and the environment to this
stability. The most important finding from our study is that the
stability of both cortisol production and metabolism over time
is low, so that in view of the limited number of participants, genetic
versus environmental contributions to this stability are difficult to
assess.
It has previously been demonstrated that only a small propor-
tion of the variance in salivary cortisol level shows a stable pattern
(Platje et al., 2013; Ross et al., 2014; Shirtcliff et al., 2012), and that
approximately 50% of this variance could be explained by day-to-
day fluctuations (Ross et al., 2014). In children aged 9–15 years,
only 13% of the variance in salivary cortisol level showed stability
over the years (Shirtcliff et al., 2012). However, these studies had
only measured cortisol in saliva and hence could not distinguish
between cortisol production and elimination.
In contrast, a recent study among adolescents demonstrated a
higher long-term stability of cortisol production, as assessed by
hair cortisol concentration (HCC), namely a two-year’s stability
of 0.32 [95% CI (0.16, 0.45); Rietschel et al., 2017]. Measurement
of HCC is a relatively new method that enables the assessment of
cortisol production over a prolonged period (with 1 cm of hair seg-
ment representing cortisol production over a period of 1 month).
HCC is therefore less sensitive to daily fluctuations in the secretion
of cortisol, such as the diurnal rhythm, nutrition and physical
activity, as compared to measurement of cortisol in blood, saliva
or urine (Stalder et al., 2012). As we measured cortisol metabolites
in morning urine, our study might have underestimated the long-
term stability of cortisol production. However, HCC only repre-
sents cortisol production, and a major disadvantage of this tech-
nique compared to ours is that it could not distinguish between
cortisol production and metabolism.
We have previously demonstrated that both genetic and envi-
ronmental factors contributed to cortisol production and metabo-
lism throughout adolescence (van Keulen et al., 2020). Our current
findings suggest that the processes underlying these contributions
are highly dynamic over time. Indeed, it is possible that during ado-
lescence not only environmental stressors but also genomic
influences — for example, those relevant to growth and puberty
— vary over time.
Our study has several strengths and limitations. Participants
were recruited from a population-based register, and the numbers
lost to follow-up were acceptably low. As participants were mea-
sured at fixed ages, our observations could not be explained by
variability in the timing of the assessments. However, a number
of limitations should be considered. The limited stability of cortisol
parameters over time could, in addition to the relatively small sam-
ple size, lead to unstable heritability and environmental estimates,
resulting in wide confidence intervals. Cortisol metabolites were
measured in urine samples obtained immediately after awakening.
Preferably, cortisol metabolites are measured in 24-hour’s urine
samples, as cortisol is secreted rhythmically (Young et al., 2004).
The timing of urine collection could therefore have influenced
our stability estimates.
Table 2. Associations between cortisol metabolite excretion rate and metabolism activity at different ages
Index Age (years) Rph (95% CI) rA (90% CI) rC (90% CI) rE (90% CI)
Cortisol metabolite excretion rate 9–12
12–17
9–17
0.19 (0.01, 0.37)
0.06 (−0.14, 0.24)
0.18 (−0.01, 0.35)
0.27 (−1.00, 1.00)
–
–
–
–
–
0.22 (−0.07, 0.47)
0.15 (−0.06, 0.36)
0.22 (−0.05, 0.38)
5α-reductase activity 9–12
12–17
9–17
0.25 (0.06, 0.43)
0.15 (−0.05, 0.34)
0.28 (0.08, 0.45)
0.36 (−1.00, 1.00)
0.02 (−1.00, 1.00)
0.27 (−1.00, 1.00)
0.76 (NA, 1.00)
1.00 (−1.00, 1.00)
0.77 (−1.00, 1.00)
−0.30 (−0.56, 0.03)
−0.13 (−0.57, 0.39)
−0.03 (−0.36, 0.31)
5β-reductase activity 9–12
12–17
9–17
0.26 (0.10, 0.40)
0.12 (−0.05, 0.28)
0.11 (−0.06, 0.27)
0.89 (0.42, 1.00)
0.55 (0.16, 0.93)
0.11 (−0.29, 0.64)
–
–
–
−0.07 (−0.28, 0.17)
−0.31 (−0.53, 0.04)
0.03 (−0.23, 0.29)
11β-HSD type 2 activity 9–12
12–17
9–17
0.27 (0.11, 0.41)
0.07 (−0.11, 0.26)
0.09 (−0.09, 0.25)
0.85 (0.40, 1.00)
0.35 (−0.11, 1.00)
0.79 (NA, 1.00)
–
–
–
−0.00 (−0.23, 0.24)
−0.16 (−0.42, 0.12)
−0.12 (−0.33, 0.09)
Cytochrome P450 3A4 activity 9–12
12–17
9–17
0.46 (0.28, 0.60)
−0.02 (−0.20, 0.17)
0.16 (−0.03, 0.33)
0.86 (0.54–1.00)
−0.08 (−0.45–0.23)
0.26 (−0.28–0.66)
–
–
–
0.04 (−0.36, 0.44)
0.12 (−0.20, 0.42)
0.04 (−0.37, 0.43)
Note: CI, confidence interval; HSD, hydroxysteroid dehydrogenase. Phenotypic correlations (Rph, calculated as, e.g., h9 * rA9,12 * h12þ c9 * rC9,12 * c12þ e9 * rE9,12 * e12) between ages 9–12 years,
12–17 years and 9–17 years are depictedwith their 95% confidence intervals. Bolded phenotypic correlations are significant at p value< .05. Genetic (rA), common environmental (rC) and unique
environmental correlations (rE) acting on both ages are given with their 90% confidence intervals. Bold typed genetic correlations are significant at p value < .10.
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Fig. 3. Path diagram representing the correlations between genetic (A), shared environmental (C) and unique environmental (E) influences between ages 9–12 years,
12–17 years and 9–17 years and the influences of genetic and environmental factors on the phenotypic variance at the ages of 9, 12 and 17 years. (A) Cortisol metabo-
lite excretion rate, (B) 5α-reductase activity, (C) 5β-reductase activity, (D) 11β-HSD type 2 activity and (E) cytochrome P450 3A4 activity.
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Conclusion
Our current findings showed that the stability in both cortisol pro-
duction and metabolism, as assessed in early-morning urine,
between ages 9 and 17 years is low, reflecting the dynamic nature
of the HPA axis.
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